Hemispherx BioPharma, Inc. Competitors

HEB 
$0.23
*  
0.0049
2.09%
Get HEB Alerts
*Delayed - data as of May 22, 2015  -  Find a broker to begin trading HEB now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    HEB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Hemispherx BioPharma, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap ▼
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 111.71 0.49 ▲ 12,075,786 $ 112.66
$ 110.70
$ 116.83
$ 78.50
12.68 166,381,097,420
Amgen Inc.
AMGN: NASDAQ-GS
$ 163.58 -0.26 ▼ 1,634,558 $ 164.57
$ 163.03
$ 173.60
$ 113.56
22.08 124,134,482,380
Biogen Inc.
BIIB: NASDAQ-GS
$ 398.68 -2.47 ▼ 829,439 $ 401.7899
$ 397.40
$ 480.18
$ 290.85
28.76 93,535,909,520
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 218.11 2.32 ▲ 862,930 $ 218.80
$ 214.94
$ 218.80
$ 60.19
NE 8,060,909,380
Qiagen N.V.
QGEN: NASDAQ-GS
$ 25.11 0.06 ▲ 408,427 $ 25.20
$ 24.89
$ 25.91
$ 20.73
53.43 5,859,544,050
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 178.38 5.44 ▲ 994,970 $ 179.48
$ 166
$ 186.36
$ 20.01
NE 5,809,123,080
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 43.23 -0.53 ▼ 874,141 $ 44.3899
$ 42.8001
$ 44.95
$ 30.05
NE 5,374,310,370
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 46.78 0.44 ▲ 697,274 $ 47.1465
$ 45.58
$ 66
$ 34.71
NE 4,230,128,280
Bio-Techne Corp
TECH: NASDAQ-GS
$ 102.61 -0.15 ▼ 87,132 $ 103.38
$ 102.04
$ 103.38
$ 85.96
35.38 3,810,319,740
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 42.55 0.57 ▲ 1,276,223 $ 43.67
$ 41.98
$ 45.36
$ 12.6325
NE 3,625,515,300
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 109.24 1.37 ▲ 57,645 $ 109.26
$ 107.6955
$ 109.26
$ 37.50
37.67 2,693,530,680
Novavax, Inc.
NVAX: NASDAQ-GS
$ 8.87 0.01 ▲ 1,508,792 $ 8.9899
$ 8.81
$ 9.95
$ 3.92
NE 2,375,785,150
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 52.85 0.54 ▲ 1,100,449 $ 53.21
$ 51.66
$ 89.21
$ 21
NE 2,247,234,850
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 17.45 0.20 ▲ 793,604 $ 17.58
$ 16.97
$ 17.63
$ 7.51
NE 2,188,003,150
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 9.07 0.23 ▲ 2,855,118 $ 9.07
$ 8.82
$ 9.89
$ 4.90
NE 1,698,012,840
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 67.53 -0.92 ▼ 198,149 $ 69
$ 66.09
$ 79.50
$ 40.16
NE 1,657,456,320
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 32.01 -0.25 ▼ 476,003 $ 32.19
$ 31.92
$ 45.45
$ 28.26
97 1,362,825,750
Repligen Corporation
RGEN: NASDAQ-GS
$ 40.88 -0.31 ▼ 248,463 $ 41.71
$ 40.60
$ 42.43
$ 18.23
194.67 1,337,675,360
Cellectis S.A.
CLLS: NASDAQ-GM
$ 34 3.20 ▲ 1,688,539 $ 37.47
$ 31.765
$ 42.04
$ 30.40
NE 1,120,946,000
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 19.88 0.57 ▲ 785,540 $ 19.91
$ 19.08
$ 20.75
$ 9.38
NE 1,092,863,240
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 6.66 0.02 ▲ 1,337,568 $ 6.71
$ 6.61
$ 10.26
$ 6.38
3.42 1,083,921,660
Adaptimmune Therapeutics plc
ADAP: NASDAQ-GS
$ 15.60 0.52 ▲ 78,605 $ 15.71
$ 14.84
$ 19.50
$ 14
NE 1,074,996,000
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 32.92 -0.11 ▼ 104,756 $ 33.33
$ 32.44
$ 48.50
$ 23.61
NE 1,061,768,760
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 24.66 -0.43 ▼ 98,361 $ 25.20
$ 24.6299
$ 28.50
$ 20.2601
NE 955,451,700
Avalanche Biotechnologies, Inc.
AAVL: NASDAQ-GM
$ 38.03 -0.80 ▼ 204,109 $ 39.30
$ 37.58
$ 62.48
$ 22
NE 955,427,690